Lateral Epicondylitis Treatment High Intensive Laser Therapy and Extracorporeal Shock Wave Therapy

NCT ID: NCT06301152

Last Updated: 2024-03-08

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

40 participants

Study Classification

INTERVENTIONAL

Study Start Date

2022-09-01

Study Completion Date

2023-05-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Objectives: This study aims to evaluate and compare the short-term efficacy of high-intensity laser therapy (HILT) and extra corporeal shock wave therapy(ESWT) on pain, sensitivity, handgrip strength, and functions in the treatment of lateral epicondylitis (LE).

Material and methods: Forty five participants (age range, 18 to 65 years) with unilateral elbow pain were randomized into two groups. HILT group (n = 22) and the ESWT group (n = 23). The HILT and ESWT were administered three times a week for three weeks, and each treatment was combined with exercises. All patients in both groups were evaluated with ultrasonography for common extensor tendon(CET) thickness. A visual analog scale (VAS), Quick Disabilities of the Arm, Shoulder, and Hand (QDASH), and hand grip strength test were used to evaluate the patients before, one, and six weeks after treatment.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Lateral Epicondylitis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

two different treatment modalities were applied in two groups
Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

high intensive laser

high-intensity laser was applied 3 times in a week, for three weeks, total of 9 sessions

Group Type EXPERIMENTAL

high intensive laser

Intervention Type DEVICE

high-intensity laser ,three times in a week, for three weeks, 9 session

extracorporeal shock wave therapy

extracorporeal shock wave therapy was applied once a week, for three weeks total of 3 sessions

Group Type EXPERIMENTAL

extracorporeal shock wave therapy

Intervention Type DEVICE

extracorporeal shock wave therapy, once a week, for three weeks ,3 times,

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

high intensive laser

high-intensity laser ,three times in a week, for three weeks, 9 session

Intervention Type DEVICE

extracorporeal shock wave therapy

extracorporeal shock wave therapy, once a week, for three weeks ,3 times,

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Clinical diagnosis of Lateral epicondylitis
* Age \>18

Exclusion Criteria

* Operation history about elbow
* Received physical therapy, or had a steroid injection to the elbow in the three months
* Cervical radiculopathy,
* Elbow deformities,
* Fibromyalgia syndrome,
* Carpal tunnel syndrome,
* Neurological impairments in the upper extremity,
* Chronic inflammatory conditions,
* Hemophilia,
* Pregnant,
* History of malignancy
Minimum Eligible Age

18 Years

Maximum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Ankara City Hospital Bilkent

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Emine Esra Bilir

Ankara, Çankaya, Turkey (Türkiye)

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Turkey (Türkiye)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

E2-22-1905

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.